FDAnews Drug Daily Bulletin

Northern Health Products Draws Warning Letter for Promoting Unapproved Drugs

Jan. 24, 2017

Northern Health Products received a warning letter from the FDA for promoting and selling unapproved drugs.

The agency reviewed the company’s website (www.northernhealthproducts.com) in September 2016 and determined that not all of the products offered online have been approved for sale by the agency.

In addition, claims made on the website have not been established through drug trials, including statements that the company’s DCA Cancer Treatment Kit can “be an effective tool in shrinking tumor size and mass, reversing illness, and increasing health and vitality of patients,” FDA found. inspectors also cited the firm for promoting and selling unapproved animal drugs.

View today's stories